Third Circuit Revives Suit Against GSK Over Avandia Injury Costs

The Third Circuit on Thursday revived a proposed class action from two Humana units seeking reimbursement from GlaxoSmithKline for costs borne by the insurers for treatment of Medicare patients harmed by the diabetes drug Avandia.
Law360